S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
AI healthcare stock poised for 36,996% growth? (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
How Biden has already won 2024 (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
AI healthcare stock poised for 36,996% growth? (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
How Biden has already won 2024 (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
AI healthcare stock poised for 36,996% growth? (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
How Biden has already won 2024 (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
AI healthcare stock poised for 36,996% growth? (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
How Biden has already won 2024 (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
Free Trial
TSE:AUP

Aurinia Pharmaceuticals (AUP) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free AUP Stock Alerts
Compare
Today's Range
N/A
50-Day Range
C$16.76
▼
C$16.76
52-Week Range
N/A
Volume
4.61 million shs
Average Volume
229,895 shs
Market Capitalization
C$2.15 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
AUP stock logo

About Aurinia Pharmaceuticals Stock (TSE:AUP)

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

AUP Stock News Headlines

February 29, 2024 | barrons.com
Aurinia Pharmaceuticals Inc.
February 15, 2024 | msn.com
Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
February 15, 2024 | msn.com
Exclusive-Kidney drug developer Aurinia fails to clinch a sale, sources say
February 15, 2024 | msn.com
Aurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06M
February 15, 2024 | msn.com
Aurinia drops after Q4 miss; strategic review fails
February 15, 2024 | reuters.com
Aurinia to stop development of immunotherapies after strategic review
February 15, 2024 | reuters.com
Exclusive: Kidney drug developer Aurinia fails to clinch a sale, sources say
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
February 14, 2024 | msn.com
Aurinia Pharma Q4 2023 Earnings Preview
February 8, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Arrowhead Pharmaceuticals (ARWR)
February 8, 2024 | msn.com
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
November 13, 2023 | benzinga.com
Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan
November 13, 2023 | markets.businessinsider.com
Aurinia Says Its Partner Otsuka Filed NDA For Voclosporin In Japan
November 6, 2023 | markets.businessinsider.com
Strong 3Q Performance and Growing Lupkynis Sales Bolster Aurinia Pharmaceuticals’ Buy Rating: An In-depth Analysis by David Martin, PhD
November 2, 2023 | seekingalpha.com
Aurinia Pharmaceuticals Inc. (AUPH) Q3 2023 Earnings Call Transcript
September 27, 2023 | msn.com
Aurinia Pharmaceuticals: Reassessing As It Gains Traction
August 3, 2023 | seekingalpha.com
Aurinia Pharmaceuticals Inc. (AUPH) Q2 2023 Earnings Call Transcript
July 18, 2023 | msn.com
Aurinia Pharmaceuticals Stock Returns To A Rising Relative Strength
June 29, 2023 | benzinga.com
Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
June 16, 2023 | msn.com
Aurinia Pharmaceuticals: Still In The Game With Lupkynis Sales
May 18, 2023 | msn.com
Aurinia Pharmaceuticals Earnings Perspective: Return On Capital Employed
May 17, 2023 | technews.tmcnet.com
MKT Capital Thanks Fellow Shareholders for Their Strong Support at Aurinia's 2023 Annual Meeting
May 9, 2023 | finance.yahoo.com
News Flash: Analysts Just Made A Sizeable Upgrade To Their Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Forecasts
May 6, 2023 | markets.businessinsider.com
Bloom Burton Remains a Buy on Aurinia Pharmaceuticals (AUPH)
May 5, 2023 | technews.tmcnet.com
MKT Capital Issues Statement Regarding Aurinia's Disappointing First Quarter 2023 Financial Results
May 4, 2023 | finance.yahoo.com
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
See More Headlines
Receive AUP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurinia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Computer and Technology
Industry
Technical & System Software
Sub-Industry
N/A
Current Symbol
TSE:AUP
Previous Symbol
TSE:ISA
CUSIP
N/A
CIK
N/A
Web
www.auriniapharma.com
Phone
+1-250-7084272
Fax
N/A
Employees
294
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
2.69
Current Ratio
11.93
Quick Ratio
11.02

Sales & Book Value

Annual Sales
C$57.59 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
6.75
Book Value
C$2.59 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
128,396,000
Free Float
N/A
Market Cap
C$2.15 billion
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Peter S. Greenleaf M.B.A. (Age 51)
    Pres, CEO & Director
    Comp: $1.39M
  • Mr. Joseph M. Miller CPA (Age 47)
    Chief Financial Officer
    Comp: $614.27k
  • Mr. Matthew Maxwell Donley M.B.A. (Age 52)
    Exec. VP of Operations & Strategy
    Comp: $627.51k
  • Mr. Stephen P. Robertson (Age 39)
    Exec. VP, Gen. Counsel, Corp. Sec. & Chief Compliance Officer
    Comp: $193.43k
  • Mr. Massimiliano Colao (Age 56)
    Chief Commercial Officer
    Comp: $719.79k
  • Dr. Glenn Schulman
    Sr. VP of Corp. Communications & Investor Relations
  • Mr. Chris Hays
    VP of Marketing
  • Mr. Fran Lynch
    VP of Sales
  • Dr. Robert B. Huizinga M.Sc. (Age 56)
    Ph.D., R.N., RN NNC, MSc(Epi), CNeph(C), Exec. VP of Research
  • Mr. Michael R. Martin (Age 49)
    Chief Bus. Officer

Key Competitors

View All Competitors

AUP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Aurinia Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurinia Pharmaceuticals investors own include ARC Resources (ARX), Enbridge (ENB), Aurinia Pharmaceuticals (AUPH), Brookfield Renewable Partners (BEP.UN), Costco Wholesale (COST), Parkland (PKI), Allena Pharmaceuticals (ALNA), Algonquin Power & Utilities (AQN), Brookfield Infrastructure Partners (BIP.UN) and Granite Real Estate Investment Trust (GRT.UN).

How do I buy shares of Aurinia Pharmaceuticals?

Shares of AUP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:AUP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The “Perfect Storm” for Gold
Gold Safe Exchange
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company